Office of Research - College of Osteopathic Medicine - Michigan State University

Skip To Main Content

Header Navigation

HelmetMichigan State UniversityCollege of Osteopathic MedicineCapital Campaign Link

Office of Research Continued


 

Announcements & Seminars

Designing a Mixed Methods Research Project: Interactive-Participatory Workshop November 9, 10 & 11, 2016 University of Michigan, Ann Arbor  “From Complexity to Priorities: How Mixed Methods Can Help Us Study and Improve Patient-Provider Communication” KEYNOTE SPEAKER  Marsha N. Wittink, MD, MBE, Assistant Professor, Department of Psychiatry and Family Medicine  University of Rochester Medical Center School of Medicine and Dentistry, School of Medicine and Dentistry -  Find out more and register at: www.mixedmethods.org Inquiries: Satoko Motohara (734) 998-7120 ext. 328 or smotohar@umich.edu- REGISTRATION FEE: $1,600 per participant. Registration is open. Limited seats available.http://www.mixedmethods.org/workshops.html

The Department of Sociology-presents Medicine, Health and Society Seminar 2016--November 11, 2016 --12-1:30 pm  --  Room 457, Berkey Hall  Lunch will be provided-----Shelia Cotten, Professor of Media and Information, Director of  MSU-Sparrow Center for Innovation and Research (CFIR), Director of Trifecta "Technology and Health: Expanding Boundaries and Making Connections"--Daniel Menchik, Assistant Professor of Sociology and Lyman Briggs College "Organized Indeterminacy: The Social Processes Underpinning Medical Authority"  Jennifer Carrera, Assistant Professor of Sociology and Environmental Science and Policy Program "Expert Politics and Embodied Health: How Knowledge Politics Helped to Bring About the Flint Water Crisis"--Ning Hsieh, Assistant Professor of Sociology"Functional Limitation, Subjective Well-Being, and Social Interaction in Later Life in China"

 
Building a Research Team: Researchers and Clinicians (see attached flyer) featuring Barbara Given, PhD, RN, FAAN, Interim Associate Dean for Research and CON PhD Program ,University Distinguished Professor College of Nursing ,Michigan State University, Chair, Board of Directors ,Sparrow Health System   Monday, November 14, 2016 | Noon to 1 p.m. Sparrow Professional Building, Administrative Board Room, Ste. 600 1200 E. Michigan Avenue, Lansing, MI 48912 Bring your lunch. Dessert and beverages provided. *Space is limited. Please reserve your seat by contacting the Center for Innovation and Research at 517.364.5730 or email sharon.baer@sparrow.org If you would be interested in leading a Brown Bag session in 2017, send an email to
sharon.baer@sparrow.org with your topic of interest and preferred date/month. The topic should be relevant to faculty of both Michigan State University and Sparrow Health System.

 16th Annual Pediatric Research Day Precision Medicine in Pediatrics, March 29, 2017, 8:00 a.m. - 5:00 p.m., McGregor Memorial Conference Center, Wayne State University- McGregor Memorial Conference Center--Wayne State University  Keynote  Speakers:Steven D. Colan, MD, FACC, FASE
Donald C. Fyler Professor of Pediatrics, Harvard Medical SchoolJoseph G. Gleeson, MD,  Rady Professor of Neuroscience, University of California
Stephen E. Sallan, MD, Professor of Pediatrics, Harvard Medical School, Dana-Farber Cancer Institute

Sparrow/MSU Center for Innovation and Research Open House Friday, December 9, 2016 - 11:00 a.m. to 2:00 p.m. -

Funding Announcements

Requests for Applications

  • Exosomes: From Biogenesis and Secretion to the Early Pathogenesis of Alzheimer's Disease (R01)
    (RFA-AG-17-051)
    National Institute on Aging
    Application Receipt Date(s): February 3, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
  • Understanding the Effects of ApoE2 on the Interaction between Aging and Alzheimers Disease (R01)
    (RFA-AG-17-056)
    National Institute on Aging
    Application Receipt Date(s): February 10, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
  • Multimorbidity in Alzheimers Disease Impacts Choice of Ancillary Treatments (R21/R33)
    (RFA-AG-17-059)
    National Institute on Aging
    Application Receipt Date(s): January 12, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
  • Multimorbidity in Alzheimers Disease Impacts Choice of Ancillary Treatments (R33)
    (RFA-AG-17-060)
    National Institute on Aging
    Application Receipt Date(s): January 12, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
  • Research Centers for Population-based Research to Optimize Cancer Screening (PROSPR) Initiative (UM1)
    (RFA-CA-16-016)
    National Cancer Institute
    Application Receipt Date(s): February 9, 2017, by 5:00 PM local time of applicant organization. All applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for the Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  • Coordinating Center for Population-based Research to Optimize Cancer Screening (PROSPR) (U24)
    (RFA-CA-16-017)
    National Cancer Institute
    Application Receipt Date(s): February 9, 2017, by 5:00 PM local time of applicant organization. All applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for the Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  • Pilot Clinical Trials in Pediatric Chronic Kidney Disease Participating Clinical Centers (U01)
    (RFA-DK-16-018)
    National Institute of Diabetes and Digestive and Kidney Diseases
    Application Receipt Date(s): February 17, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
  • Pilot Clinical Trials in Pediatric Chronic Kidney Disease Data Coordinating Center (U24)
    (RFA-DK-16-035)
    National Institute of Diabetes and Digestive and Kidney Diseases
    Application Receipt Date(s): February 17, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
  • NIH Revision Awards for Creating Virtual Consortium for Translational/Transdisciplinary Environmental Research (ViCTER)(R01)
    (RFA-ES-17-002)
    National Institute of Environmental Health Sciences
    Application Receipt Date(s): March 7, 2017; March 6, 2018; March 6, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
  • Circadian Mechanisms Contributing to Obesity, Diabetes Metabolism, and Underlying Heart, Lung, and Blood Disorders (R01)
    (RFA-HL-17-020)
    National Heart, Lung, and Blood Institute
    National Institute of Diabetes and Digestive and Kidney Diseases
    Application Receipt Date(s): March 14, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.

Program Announcements

  • Role of Age-Associated Metabolic Changes in Alzheimer's Disease (AD) (R01)
    (PAR-17-031)
    National Institute on Aging
    Application Receipt/Submission Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
  • Translational Bioinformatics Approaches to Advance Drug Repositioning and Combination Therapy Development for Alzheimers Disease (R01)
    (PAR-17-032)
    National Institute on Aging
    Application Receipt/Submission Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  • Integrative Research to Understand the Impact of Sex Differences on the Molecular Determinants of AD Risk and Responsiveness to Treatment (R01)
    (PAR-17-033)
    National Institute on Aging
    Application Receipt/Submission Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  • NIDDK Exploratory Clinical Trials for Small Business (R44)
    (PAR-17-034)
    National Institute of Diabetes and Digestive and Kidney Diseases
    Application Receipt/Submission Date(s): Standard dates apply, by 5:00 PM local time of applicant organization.
  • Platform Delivery Technologies for Nucleic Acid Therapeutics (R43/R44)
    (PAR-17-035)
    National Center for Advancing Translational Sciences
    National Institute of Allergy and Infectious Diseases
    National Institute of Biomedical Imaging and Bioengineering
    Application Receipt/Submission Date(s): Standard dates apply, by 5:00 PM local time of applicant organization.
  • Platform Delivery Technologies for Nucleic Acid Therapeutics (R41/R42)
    (PAR-17-036)
    National Center for Advancing Translational Sciences
    National Institute of Allergy and Infectious Diseases
    Application Receipt/Submission Date(s): Standard dates apply by 5:00 PM local time of applicant organization.
  • Clarifying the Relationship between Delirium and Alzheimers Disease and Related Dementias (R21/R33)
    (PAR-17-037)
    National Institute on Aging
    Application Receipt/Submission Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
  • Clarifying the Relationship between Delirium and Alzheimers Disease and Related Dementias (R01)
    (PAR-17-038)
    National Institute on Aging
    Application Receipt/Submission Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
  • Comparative Biology of Neurodegeneration (R21)
    (PAR-17-039)
    National Institute on Aging
    Application Receipt/Submission Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.